These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 28092373)

  • 21. Development of hypomelanotic macules is associated with constitutive activated mTORC1 in tuberous sclerosis complex.
    Møller LB; Schönewolf-Greulich B; Rosengren T; Larsen LJ; Ostergaard JR; Sommerlund M; Ostenfeldt C; Stausbøl-Grøn B; Linnet KM; Gregersen PA; Jensen UB
    Mol Genet Metab; 2017 Apr; 120(4):384-391. PubMed ID: 28336152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tsc1 is a Critical Regulator of Macrophage Survival and Function.
    Fang C; Yu J; Luo Y; Chen S; Wang W; Zhao C; Sun Z; Wu W; Guo W; Han Z; Hu X; Liao F; Feng X
    Cell Physiol Biochem; 2015; 36(4):1406-18. PubMed ID: 26159807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. mTORC1 Inhibition Corrects Neurodevelopmental and Synaptic Alterations in a Human Stem Cell Model of Tuberous Sclerosis.
    Costa V; Aigner S; Vukcevic M; Sauter E; Behr K; Ebeling M; Dunkley T; Friedlein A; Zoffmann S; Meyer CA; Knoflach F; Lugert S; Patsch C; Fjeldskaar F; Chicha-Gaudimier L; Kiialainen A; Piraino P; Bedoucha M; Graf M; Jessberger S; Ghosh A; Bischofberger J; Jagasia R
    Cell Rep; 2016 Apr; 15(1):86-95. PubMed ID: 27052171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The orphan receptor TR3 participates in angiotensin II-induced cardiac hypertrophy by controlling mTOR signalling.
    Wang RH; He JP; Su ML; Luo J; Xu M; Du XD; Chen HZ; Wang WJ; Wang Y; Zhang N; Zhao BX; Zhao WX; Shan ZG; Han J; Chang C; Wu Q
    EMBO Mol Med; 2013 Jan; 5(1):137-48. PubMed ID: 23197407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic reprogramming and macrophage polarization in granuloma formation.
    Nakamizo S; Kabashima K
    Int Immunol; 2024 Jun; 36(7):329-338. PubMed ID: 38441292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The cochaperone BAG3 coordinates protein synthesis and autophagy under mechanical strain through spatial regulation of mTORC1.
    Kathage B; Gehlert S; Ulbricht A; Lüdecke L; Tapia VE; Orfanos Z; Wenzel D; Bloch W; Volkmer R; Fleischmann BK; Fürst DO; Höhfeld J
    Biochim Biophys Acta Mol Cell Res; 2017 Jan; 1864(1):62-75. PubMed ID: 27756573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of tuberous sclerosis complex 1 in regulating innate immunity.
    Pan H; O'Brien TF; Zhang P; Zhong XP
    J Immunol; 2012 Apr; 188(8):3658-66. PubMed ID: 22412198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. mTORC1 is a target of nordihydroguaiaretic acid to prevent breast tumor growth in vitro and in vivo.
    Zhang Y; Xu S; Lin J; Yao G; Han Z; Liang B; Zou Z; Chen Z; Song Q; Dai Y; Gao T; Liu A; Bai X
    Breast Cancer Res Treat; 2012 Nov; 136(2):379-88. PubMed ID: 23053656
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NFκB up-regulation of glucose transporter 3 is essential for hyperactive mammalian target of rapamycin-induced aerobic glycolysis and tumor growth.
    Zha X; Hu Z; Ji S; Jin F; Jiang K; Li C; Zhao P; Tu Z; Chen X; Di L; Zhou H; Zhang H
    Cancer Lett; 2015 Apr; 359(1):97-106. PubMed ID: 25578782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of autophagy during ECM detachment is linked to a selective inhibition of mTORC1 by PERK.
    Avivar-Valderas A; Bobrovnikova-Marjon E; Alan Diehl J; Bardeesy N; Debnath J; Aguirre-Ghiso JA
    Oncogene; 2013 Oct; 32(41):4932-40. PubMed ID: 23160380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lysosomal recruitment of TSC2 is a universal response to cellular stress.
    Demetriades C; Plescher M; Teleman AA
    Nat Commun; 2016 Feb; 7():10662. PubMed ID: 26868506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p62/SQSTM1 Cooperates with Hyperactive mTORC1 to Regulate Glutathione Production, Maintain Mitochondrial Integrity, and Promote Tumorigenesis.
    Lam HC; Baglini CV; Lope AL; Parkhitko AA; Liu HJ; Alesi N; Malinowska IA; Ebrahimi-Fakhari D; Saffari A; Yu JJ; Pereira A; Khabibullin D; Ogorek B; Nijmeh J; Kavanagh T; Handen A; Chan SY; Asara JM; Oldham WM; Diaz-Meco MT; Moscat J; Sahin M; Priolo C; Henske EP
    Cancer Res; 2017 Jun; 77(12):3255-3267. PubMed ID: 28512249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of Downstream mTORC1 Target Ribosomal Protein S6 Kinase (S6K) Can Be Found in a Subgroup of Dutch Patients with Granulomatous Pulmonary Disease.
    Kraaijvanger R; Seldenrijk K; Beijer E; Damen J; Wilson JL; Weichhart T; Grutters JC; Veltkamp M
    Cells; 2021 Dec; 10(12):. PubMed ID: 34944053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic Strategy for Targeting Aggressive Malignant Gliomas by Disrupting Their Energy Balance.
    Hegazy AM; Yamada D; Kobayashi M; Kohno S; Ueno M; Ali MA; Ohta K; Tadokoro Y; Ino Y; Todo T; Soga T; Takahashi C; Hirao A
    J Biol Chem; 2016 Oct; 291(41):21496-21509. PubMed ID: 27519418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mourning Dr. Alfred G. Knudson: the two-hit hypothesis, tumor suppressor genes, and the tuberous sclerosis complex.
    Hino O; Kobayashi T
    Cancer Sci; 2017 Jan; 108(1):5-11. PubMed ID: 27862655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metformin Inhibits Hepatic mTORC1 Signaling via Dose-Dependent Mechanisms Involving AMPK and the TSC Complex.
    Howell JJ; Hellberg K; Turner M; Talbott G; Kolar MJ; Ross DS; Hoxhaj G; Saghatelian A; Shaw RJ; Manning BD
    Cell Metab; 2017 Feb; 25(2):463-471. PubMed ID: 28089566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. mTORC1: turning off is just as important as turning on.
    Benjamin D; Hall MN
    Cell; 2014 Feb; 156(4):627-8. PubMed ID: 24529368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CXCL12-induced macropinocytosis modulates two distinct pathways to activate mTORC1 in macrophages.
    Pacitto R; Gaeta I; Swanson JA; Yoshida S
    J Leukoc Biol; 2017 Mar; 101(3):683-692. PubMed ID: 28250113
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aberrant differentiation of Tsc2-deficient teratomas associated with activation of the mTORC1-TFE3 pathway.
    Kawano H; Ito Y; Kanai F; Nakamura E; Tada N; Takai S; Horie S; Kobayashi T; Hino O
    Oncol Rep; 2015 Nov; 34(5):2251-8. PubMed ID: 26352760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dengue Virus Activates the AMP Kinase-mTOR Axis To Stimulate a Proviral Lipophagy.
    Jordan TX; Randall G
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28298606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.